Previous research has suggested a potential link between the antiviral activity of sophoridine and its ability to inhibit the activation of cellular PI3K-Akt and P38 MAPK pathways during herpesvirus infection [28]. This evidence concerns the gene AKT1 and Herpesviridae infectious disease.